UW Health oncologist shares signs and symptoms of kidney cancer
Kidney Cancer is among the 10 most common cancers in both men and women in the United States. The American Cancer Society ...
CURE2d
Fruzaqla Plus Sintilimab May Slow Renal Cell Carcinoma Progression
Fruzaqla given in combination with sintilimab slowed progression in the second line for those with locally advanced or metastatic renal cell carcinoma.
The Manila Times2d
Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, today announced a €20 million ($21.9 million) financing through the issuance of a Mandatory ...
The Pharma Letter3d
Hutchmed and Innovent’s double act effective in advanced RCC
Chinese pair Hutchmed and Innovent Biologics have announced that the FRUSICA-2 Phase II/III trial of fruquintinib and ...
Clinical Trials Arena3d
Innovent & HUTCHMED seek approval of kidney cancer combo after Phase II/III trial
Innovent and HUTCHMED received conditional approval for the combo in endometrial cancer from China’s NMPA last year.
Exelixis Growth Continues with Big Money Boosts
EXEL discovers, develops, and commercializes new treatments to battle hard-to-treat cancers. Its product portfolio continues ...
Oncorena receives FDA approval to initiate studies in the US
Oncorena is pleased to announce that the FDA has approved the Company's IND application to initiate the Phase I/II study Oncorella-1: A Phase 1/2, open label, single arm study on safety, tolerability ...
The Manila Times4d
New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution
Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation ...
CURE4d
SBRT May Offer Best Control Rates for Larger RCC Tumors, Study Finds
Among patients with renal cell carcinoma, those with larger tumors may yield the most benefit from SBRT compared with other ...
Dwyane Wade’s shocking cancer diagnosis: NBA legend opens up on his battle
Dwyane Wade, former NBA star, revealed a shocking cancer diagnosis that led to the removal of nearly half his kidney.
Renal & Urology News7d
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin ...